Post-market Surveillance Study to Evaluate the Quality of Life and the Safety and Effectiveness of the TIGR® Matrix After Reconstructive Breast Surgery

RecruitingOBSERVATIONAL

Enrollment

135

Participants

Timeline

Start Date

November 8, 2024

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions

Implant Based Breast Reconstruction

Interventions

DEVICE

TIGR® Matrix

bioresorbable, synthetic, surgical mesh

Trial Locations (5)

RECRUITING

Evangelisches Krankenhaus Wesel, Wesel

RECRUITING

Agaplesion Markus Krankenhaus Frankfurt, Frankfurt am Main

ACTIVE_NOT_RECRUITING

GRN-Klinik Weinheim, Weinheim

RECRUITING

Klinik und Poliklinik für Frauenheilkunde Technische Universität München, München

RECRUITING

Krankenhaus St. Elisabeth und St. Barbara Halle (Saale) GmbH, Halle

All Listed Sponsors

collaborator

Esculape GmbH

UNKNOWN

lead

AWOgyn

OTHER